Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Consensus Rating of “Moderate Buy ...

Retrieved on: 2025-04-30 06:44:48

Tags for this article:

Click the tags to see associated articles and topics

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Consensus Rating of “Moderate Buy .... View article details on hiswai:

Excerpt

Millennium Management LLC now owns 896,987 shares of the biotechnology company's stock worth $5,158,000 after acquiring an additional 165,692 shares ...

Article found on: www.defenseworld.net

View Original Article